US Broker Ratings

Takeda Pharmaceutical Company L (TAK): Investor Outlook on a 9.71% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a stalwart in the pharmaceutical industry, commands attention with its robust market presence and innovative drug portfolio. With a market..

Charles River Laboratories (CRL) Stock Analysis: Exploring a 28.56% Potential Upside

Investors eyeing opportunities in the healthcare sector might find Charles River Laboratories International, Inc. (NYSE: CRL) an enticing prospect, especially given its significant potential upside. With..

Masimo Corporation (MASI) Stock Analysis: Navigating Healthcare Innovation with Strong Revenue Growth

Masimo Corporation (NASDAQ: MASI), a stalwart in the healthcare sector, particularly within the medical devices industry, continues to capture investor attention with its innovative approach to..

BioNTech SE (BNTX) Stock Analysis: Navigating a 48% Potential Upside Amidst Volatile Financials

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has garnered significant attention from investors worldwide, particularly for its pioneering work in developing immunotherapies..

Avantor, Inc. (AVTR) Stock Analysis: Evaluating a Potential 44.57% Upside in the Healthcare Sector

Avantor, Inc. (NYSE: AVTR), a key player in the healthcare sector, specializes in providing mission-critical products and services across a diverse range of industries including biopharma,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 46% Potential Upside in the Healthcare Sector

Grifols, S.A. (NYSE: GRFS), a major player in the healthcare sector, has caught the attention of investors with its promising potential for significant upside. With a..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 26% Potential Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS) stands as a prominent player in the healthcare sector, particularly within the medical care facilities industry. This German-based company, with..

IDEXX Laboratories, Inc. (IDXX) Stock Report: Evaluating a 29.96% Potential Upside in the Diagnostics Leader

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research sector, is making waves in the healthcare industry with its innovative solutions for..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: A 14.66% Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) is making waves in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $13.56..

Veeva Systems Inc. (VEEV) Stock Analysis: Healthcare Tech Leader with a 47% Upside Potential

Veeva Systems Inc. (NYSE: VEEV), a prominent player in the healthcare sector, specializes in providing cloud-based software solutions tailored for the life sciences industry. With a..

Henry Schein, Inc. (HSIC) Stock Analysis: Unveiling a 24.50% Potential Upside in Medical Distribution

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector’s medical distribution industry, is currently showcasing intriguing investment potential. With a market capitalization of $8.51..

Tempus AI, Inc. (TEM): Investor Outlook on a Healthcare Tech Innovator with 65.95% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a leading player in the healthcare technology sector, is capturing investor attention with its impressive growth trajectory and potential upside of..

Repligen Corporation (RGEN) Stock Analysis: Exploring a Potential 63% Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers an intriguing investment opportunity for those..

Bio-Techne Corp (TECH) Stock Analysis: 46% Potential Upside Beckons Investors

Bio-Techne Corporation (NASDAQ: TECH), a leading player in the biotechnology sector, has captured investor interest with a significant potential upside of 46.17%. This Minneapolis-based company, with..

Solventum Corporation (SOLV) Stock Analysis: Exploring a 37% Potential Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a prominent player in the healthcare sector, is capturing investor interest with its notable potential upside of 37.07%. As a company that..

Moderna, Inc. (MRNA) Stock Analysis: Understanding the Biotech Giant’s Upside Potential and Current Challenges

Moderna, Inc. (NASDAQ: MRNA), a prominent name in the biotechnology sector, has been a significant player in the global healthcare landscape, particularly with its pioneering work..

Incyte Corporation (INCY) Investor Outlook: Exploring a 18.52% Potential Upside Amid Robust Growth

Incyte Corporation (NASDAQ: INCY), a leading player in the biotechnology sector, presents a compelling narrative for investors seeking exposure to the healthcare industry. With a market..

Exact Sciences Corporation (EXAS) Stock Analysis: Strong Revenue Growth Amid Valuation Concerns

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is making waves with its innovative cancer screening and diagnostic..

Ascendis Pharma A/S (ASND) Stock Analysis: Exploring a Potential 30% Upside with Strong Buy Ratings

For investors eyeing opportunities within the biopharmaceutical sector, Ascendis Pharma A/S (NASDAQ: ASND) stands out with a compelling narrative driven by innovative therapies and a robust..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: 32.58% Potential Upside Promises Growth for Investors

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a stalwart in the global healthcare sector, has recently caught the attention of investors with its substantial growth potential. Operating..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds